Members News
16/09/2020 Barrington James grows and excels through Covid-19 in Asia...more
16/09/2020 Pneumagen Announces Scientific Advisory Board and Development Team Appointments...more
15/09/2020 Barrington James shines a medical spotlight on Clinical Development...more
14/09/2020 Arcinova's Accelerated Formulation Case Study Released...more
10/09/2020 Arcinova's Steve Bagshaw featured in BBC Inside Science podcast...more
10/09/2020 Barrington James welcomes staff to their new home ...more
09/09/2020 DIT highlights XenoGesis: A winning strategy for international success...more
09/09/2020 Sygnature Discovery appoints Dr Andy Mead at RenaSci...more
08/09/2020 Arcinova shortlisted for best CRO in the OBN (UK) Ltd Awards...more
08/09/2020 Astex Pharmaceuticals and MD Anderson Announce Strategic Collaboration...more
08/09/2020 Silence Therapeutics announces complettion of NASDAQ listing...more
08/09/2020 Spotlight on Formulation – XenoGesis interviews Rob Harris...more
02/09/2020 Almac Group announces donations of £250,000 to 33 charities globally ...more
Members News Archive
Abzena
Albumedix
Alderley Park
Almac Group
Almac Discovery
Amphista - coming soon
Aptus Clinical
Arcinova
Astex Pharmaceuticals
Barrington James
BIA
Bionow
BioPartner UK
bit bio
Cello Health Consulting
Curileum Discovery
ERA Consulting
Eurofins Selcia Drug Discovery
Fusion Antibodies
IDACO Consulting
Intract Pharma
Isogenica
J A Kemp
Karma Oncology
Mawdsleys - coming soon
Medherant
MediWales
MGB Biopharma
Mironid
OBN (UK)
OFX
Oncimmune
One Nucleus
Oxstem
Parkinson's Concierge
Pebmond Associates
Pneumagen
Precision For Medicine
Sareum
Scendea
Sekisui Diagnostics
Shift Bioscience
Silence Therapeutics
Sphere Fluidics
Sygnature Discovery
SYNthesis Research and SYNthesis Med Chem
Worldwide Clinical Trials
XenoGesis
Members - send your news for inclusion!
Non-members - join here!
Not listed? renew your lapsed membership here!
BioPartner is an accredited trade organisation (ATO) subject to terms and conditions. Any claims to discounts, offers and invitations are subject to availability.
